Iftekhar D. Kalsekar, Ph.D. - Publications

Affiliations: 
2004 West Virginia University, Morgantown, WV, United States 
Area:
Pharmacy, Public Health

33/98 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Angelo RN, Rahman M, Khanna R, Yeh RW, Goldstein L, Yadalam S, Kalsekar I, Tung P, Zimetbaum PJ. Limited Duration of Antiarrhythmic Drug Use For Newly Diagnosed Atrial Fibrillation in a Nationwide Population Under Age 65. Journal of Cardiovascular Electrophysiology. PMID 33760297 DOI: 10.1111/jce.15012  0.459
2020 Mehta V, Boo LM, Ghaly N, Kalsekar I, Zhang S, Yadalam S, Khanna R, Rahman M. Real-world characteristics and readmissions among patients undergoing ablation for ventricular tachycardia: a retrospective database analysis of commercially insured patients in the USA. Open Heart. 7. PMID 32998979 DOI: 10.1136/openhrt-2020-001247  0.478
2020 Costea A, Goldstein L, Maccioni S, Kalsekar I, Khanna R. Real-world outcomes comparison among adults with atrial fibrillation undergoing catheter ablation with a contact force porous tip catheter versus a second-generation cryoballoon catheter: a retrospective analysis of multihospital US database. Bmj Open. 10: e035499. PMID 32759243 DOI: 10.1136/bmjopen-2019-035499  0.471
2020 Friedman DJ, Pokorney SD, Ghanem A, Marcello S, Kalsekar I, Yadalam S, Akar JG, Freeman JV, Goldstein L, Khanna R, Piccini JP. Predictors of Cardiac Perforation With Catheter Ablation of Atrial Fibrillation. Jacc. Clinical Electrophysiology. 6: 636-645. PMID 32553212 DOI: 10.1016/J.Jacep.2020.01.011  0.439
2020 D'Angelo RN, Khanna R, Yeh RW, Goldstein L, Kalsekar I, Marcello S, Tung P, Zimetbaum PJ. Trends and predictors of early ablation for Atrial Fibrillation in a Nationwide population under age 65: a retrospective observational study. Bmc Cardiovascular Disorders. 20: 161. PMID 32252637 DOI: 10.1186/s12872-020-01446-9  0.459
2020 Field ME, Goldstein L, Yu Lee SH, Kalsekar I, Coplan P, Wong C, Khanna R, Gold MR, Reynolds MR, Winterfield JR. Intracardiac echocardiography use and outcomes after catheter ablation of ventricular tachycardia. Journal of Comparative Effectiveness Research. PMID 32134325 DOI: 10.2217/cer-2019-0156  0.453
2019 Field ME, Gold MR, Reynolds MR, Goldstein L, Lee SHY, Kalsekar I, Coplan P, Wong C, Khanna R, Winterfield JR. Real-World Outcomes of Ventricular Tachycardia Catheter Ablation with versus without Intracardiac Echocardiography. Journal of Cardiovascular Electrophysiology. PMID 31868258 DOI: 10.1111/jce.14324  0.455
2019 Rai AT, Crivera C, Kottenmeier E, Kalsekar I, Kumari R, Patino N, Chekani F, Khanna R. Outcomes associated with endovascular treatment among patients with acute ischemic stroke in the USA. Journal of Neurointerventional Surgery. PMID 31649206 DOI: 10.1136/neurintsurg-2019-015378  0.45
2019 Rai AT, Crivera C, Kalsekar I, Kumari R, Patino N, Chekani F, Khanna R. Endovascular Stroke Therapy Trends From 2011 to 2017 Show Significant Improvement in Clinical and Economic Outcomes. Stroke. STROKEAHA119025112. PMID 31104618 DOI: 10.1161/STROKEAHA.119.025112  0.449
2018 Pollak SJ, Goldstein L, Daskiran M, Kalsekar I, Khanna R. Economic impact of atrial fibrillation ablation with radiofrequency contact force catheter versus cryoballoon catheter. Journal of Comparative Effectiveness Research. PMID 30572711 DOI: 10.2217/cer-2018-0112  0.457
2018 Jarman JWE, Hussain W, Wong T, Markides V, March J, Goldstein L, Liao R, Kalsekar I, Chitnis A, Khanna R. Resource use and clinical outcomes in patients with atrial fibrillation with ablation versus antiarrhythmic drug treatment. Bmc Cardiovascular Disorders. 18: 211. PMID 30404603 DOI: 10.1186/s12872-018-0946-6  0.486
2018 Chinitz L, Goldstein LJ, Barnow A, Maccioni S, Daskiran M, Kalsekar I, Khanna R. Comparison of real-world clinical and economic outcomes between the ThermoCool SF and ThermoCool catheters in patients undergoing radiofrequency catheter ablation for atrial fibrillation. Clinicoeconomics and Outcomes Research : Ceor. 10: 587-599. PMID 30323636 DOI: 10.2147/CEOR.S180125  0.479
2018 Barnow A, Canfield T, Liao R, Yadalam S, Kalsekar I, Khanna R. Breast Reconstruction Among Commercially Insured Women With Breast Cancer in the United States. Annals of Plastic Surgery. PMID 29781849 DOI: 10.1097/SAP.0000000000001454  0.37
2018 Barnow A, Goldstein L, Kalsekar I, Liao R, Khanna R. Use of the THERMOCOOL SMARTTOUCH Catheter for ablation of atrial fibrillation: the relationship between hospital procedure volume, readmissions and economic outcomes. Journal of Medical Economics. 1-16. PMID 29297705 DOI: 10.1080/13696998.2018.1423566  0.461
2010 Kalsekar I, Record S, Nesnidal K, Hancock B. National estimates of enrollment in disease management programs in the United States: an analysis of the National Ambulatory Medical Care Survey data. Population Health Management. 13: 183-8. PMID 20735245 DOI: 10.1089/Pop.2009.0056  0.303
2008 Dino G, Horn K, Abdulkadri A, Kalsekar I, Branstetter S. Cost-effectiveness analysis of the not on tobacco program for adolescent smoking cessation Prevention Science. 9: 38-46. PMID 18286372 DOI: 10.1007/S11121-008-0082-0  0.315
2007 Kalsekar I, Sheehan C, Peak A. Utilization patterns and medication adherence in patients with type 2 diabetes: Variations based on type of pharmacy (chain vs independent) Research in Social and Administrative Pharmacy. 3: 378-391. PMID 18082874 DOI: 10.1016/J.Sapharm.2006.11.002  0.341
2007 Hassan M, Madhavan SS, Kalsekar ID, Makela EH, Rajagopalan K, Islam S, Kavookjian J, Miller LA. Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder. The Annals of Pharmacotherapy. 41: 1812-8. PMID 17925501 DOI: 10.1345/Aph.1K205  0.631
2007 Mody R, Kalsekar I, Kavookjian J, Iyer S, Rajagopalan R, Pawar V. Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes. Journal of Diabetes and Its Complications. 21: 75-83. PMID 17331855 DOI: 10.1016/J.Jdiacomp.2006.02.005  0.305
2007 Hassan M, Madhavan S, Kalsekar I, Rajagopalan K, Islam S, Kavookjian J, Miller L, Makela E. PMH33 PROFILING UTILIZATION PATTERNS OF ANTIPSYCHOTICS AMONG PATIENTS WITH BIPOLAR DISORDER:A CLAIMS DATA ANALYSIS Value in Health. 10: A81. DOI: 10.1016/S1098-3015(10)68784-0  0.617
2006 Kalsekar ID, Madhavan SS, Amonkar MM, Douglas SM, Makela E, Elswick BL, Scott V. Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus: a retrospective cohort analysis. Clinical Therapeutics. 28: 306-18. PMID 16678652 DOI: 10.1016/J.Clinthera.2006.02.005  0.498
2006 Kalsekar ID, Madhavan SM, Amonkar MM, Scott V, Douglas SM, Makela E. The effect of depression on health care utilization and costs in patients with type 2 diabetes. Managed Care Interface. 19: 39-46. PMID 16583789  0.464
2006 Kalsekar ID, Madhavan SS, Amonkar MM, Makela EH, Scott VG, Douglas SM, Elswick BL. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents. The Annals of Pharmacotherapy. 40: 605-11. PMID 16551768 DOI: 10.1345/Aph.1G606  0.514
2006 Kalsekar I, Iyer S, Mody R, Rajagopalan R, Kavookjian J. Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population. Journal of Managed Care Pharmacy : Jmcp. 12: 121-9. PMID 16515370 DOI: 10.18553/Jmcp.2006.12.2.121  0.32
2006 Hassan M, Madhavan S, Rajagopalan K, Kalsekar I, Islam S, Makela E, Kavookjian J, Miller L. PMH37 COMPARING ADHERENCE AND PERSISTENCE WITH ANTIPSYCHOTIC THERAPY AMONG PATIENTS WITH BIPOLAR DISORDER Value in Health. 9: A75-A76. DOI: 10.1016/S1098-3015(10)64538-X  0.634
2006 Hassan M, Madhavan S, Rajagopalan K, Kalsekar I, Islam S, Makela E, Kavookjian J, Miller L. PMH32 ANTIPSYCHOTIC THERAPY IN PATIENTS WITH BIPOLAR DISORDER: EFFECTS ON TOTAL AND MENTAL HEALTH CARE COSTS Value in Health. 9: A74. DOI: 10.1016/S1098-3015(10)64533-0  0.617
2006 Sheehan C, Kalsekar I, Peak A. Pdb29 Impact Of Type Of Pharmacy (Chain Versus Independent) On Medication Adherence In Patients With Type 2 Diabetes: A Retrospective Database Analysis Value in Health. 9. DOI: 10.1016/S1098-3015(10)64427-0  0.302
2005 Kalsekar I, Madhavan S, Amonkar M, Douglas S, Makela E, Scott V. Pdb25 Depression In Patients With Type-2 Diabetes: Impact On Utilization Patterns And Adherence To Oral Hypoglycemic Agents Value in Health. 8: 359-360. DOI: 10.1016/S1098-3015(10)62958-0  0.316
2005 Mody R, Kalsekar I, Kavookjian J, Iyer S, Rajagopalan R, Pawar V. PDB24 ECONOMIC IMPACT OF CARDIOVASCULAR CO-MORBIDITY IN PATIENTS WITH TYPE-2 DIABETES Value in Health. 8: 359. DOI: 10.1016/S1098-3015(10)62957-9  0.307
2005 Kavookjian J, Mody R, Kalsekar I, Iyer S, Rajagopalan R, Pawar V. PDB1 PREVALENCE OF CO-MORBID CONDITIONS AND CONCOMITANT MEDICATION USE AMONG TYPE-2 DIABETES PATIENTS IN A STATE MEDICAID POPULATION Value in Health. 8: 352. DOI: 10.1016/S1098-3015(10)62934-8  0.311
2004 Dino G, Kamal K, Horn K, Kalsekar I, Fernandes A. Stage of change and smoking cessation outcomes among adolescents. Addictive Behaviors. 29: 935-40. PMID 15219338 DOI: 10.1016/J.Addbeh.2004.01.004  0.644
2004 Horn KA, Dino GA, Kalsekar ID, Fernandes AW. Appalachian teen smokers: not on tobacco 15 months later. American Journal of Public Health. 94: 181-4. PMID 14759924 DOI: 10.2105/Ajph.94.2.181  0.572
2003 Horn K, Fernandes A, Dino G, Massey CJ, Kalsekar I. Adolescent nicotine dependence and smoking cessation outcomes. Addictive Behaviors. 28: 769-76. PMID 12726789 DOI: 10.1016/S0306-4603(02)00229-0  0.571
Low-probability matches (unlikely to be authored by this person)
2005 Kalsekar I, Iyer S, Mody R, Rajagopalan R, Kavookjian J. DB2 ECONOMIC CONSEQUENCES OF CHOICE OF DIABETES THERAPY IN A MEDICAID POPULATION Value in Health. 8: 250. DOI: 10.1016/S1098-3015(10)62610-1  0.284
2005 Kalsekar I, Madhavan S, Amonkar M, Makela E, Scott V, Douglas S. Pdb2 Impact Of Depression On Incidence Of Type-2 Diabetes In A State Medicaid Population Value in Health. 8: 352. DOI: 10.1016/S1098-3015(10)62935-X  0.264
2010 Mulvaney J, Kalsekar I, Koehler J, Chavis R, Stitz L. Pcv150 Utilization Of Secondary Preventive Medications Following Acute Myocardial Infarction (Ami): A Retrospective Cohort Analysis Of A Medicaid Population Value in Health. 13. DOI: 10.1016/S1098-3015(10)72868-0  0.251
2011 Rosenbeck LL, Kiel PJ, Kalsekar I, Vargo C, Baute J, Sullivan CK, Wood L, Abdelqader S, Schwartz J, Srivastava S, Abonour R, Robertson MJ, Nelson RP, Cornetta K, Fausel CA, et al. Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 916-22. PMID 20932925 DOI: 10.1016/J.Bbmt.2010.09.017  0.244
2011 Kalsekar I, Koehler J, Mulvaney J. Impact of ACE inhibitors on mortality and morbidity in patients with AMI: Does tissue selectivity matter? Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 14: 184-91. PMID 21211501 DOI: 10.1016/J.Jval.2010.10.010  0.241
2015 Johnston SS, Nguyen H, Cappell K, Nelson JK, Chu BC, Kalsekar I. Retrospective study comparing healthcare costs and utilization between commercially insured patients with type 2 diabetes mellitus who are newly initiating exenatide once weekly or liraglutide in the United States. Journal of Medical Economics. 1-12. PMID 25867133 DOI: 10.3111/13696998.2015.1039539  0.237
2009 Maffeo C, Chase P, Brown B, Tuohy K, Kalsekar I. My First Patient Program to Introduce First-Year Pharmacy Students to Health Promotion and Disease Prevention The American Journal of Pharmaceutical Education. 73: 97-97. PMID 19885066 DOI: 10.5688/Aj730697  0.237
2016 Saunders WB, Nguyen H, Kalsekar I. Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study. Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy. 9: 217-23. PMID 27486339 DOI: 10.2147/DMSO.S103972  0.22
2012 Bergeson JG, Kalsekar I, Jing Y, You M, Forbes RA, Hebden T. Medical care costs and hospitalization in patients with bipolar disorder treated with atypical antipsychotics. American Health & Drug Benefits. 5: 379-86. PMID 24991334  0.211
2008 Kalsekar I, Latran M. Economic effect of augmentation strategies in patients with type 2 diabetes initiated on sulfonylureas. Managed Care Interface. 20: 39-46. PMID 18161391  0.21
2012 Yeung AS, Jing Y, Brenneman SK, Chang TE, Baer L, Hebden T, Kalsekar I, McQuade RD, Kurlander J, Siebenaler J, Fava M. Clinical Outcomes in Measurement-based Treatment (Comet): a trial of depression monitoring and feedback to primary care physicians. Depression and Anxiety. 29: 865-73. PMID 22807244 DOI: 10.1002/da.21983  0.201
2012 Chang TE, Jing Y, Yeung AS, Brenneman SK, Kalsekar I, Hebden T, McQuade R, Baer L, Kurlander JL, Watkins AK, Siebenaler JA, Fava M. Effect of communicating depression severity on physician prescribing patterns: findings from the Clinical Outcomes in MEasurement-based Treatment (COMET) trial. General Hospital Psychiatry. 34: 105-12. PMID 22264654 DOI: 10.1016/j.genhosppsych.2011.12.003  0.197
2012 Kalsekar I, Wagner JS, DiBonaventura M, Bates J, Forbes R, Hebden T. Comparison of health-related quality of life among patients using atypical antipsychotics for treatment of depression: results from the National Health and Wellness Survey. Health and Quality of Life Outcomes. 10: 81. PMID 22805425 DOI: 10.1186/1477-7525-10-81  0.193
2014 Citrome L, Johnston S, Nadkarni A, Sheehan JJ, Kamat SA, Kalsekar I. Prevalence of pre-existing risk factors for adverse events associated with atypical antipsychotics among commercially insured and medicaid insured patients newly initiating atypical antipsychotics. Current Drug Safety. 9: 227-35. PMID 24909573 DOI: 10.2174/1574886309666140601211551  0.193
2014 Johnston SS, Nguyen H, Felber E, Cappell K, Nelson JK, Chu BC, Kalsekar I. Retrospective study of adherence to glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes mellitus in the United States. Advances in Therapy. 31: 1119-33. PMID 25408484 DOI: 10.1007/s12325-014-0166-0  0.19
2004 Horn K, Dino G, Kalsekar I, Massey CJ, Manzo-Tennant K, McGloin T. Exploring the relationship between mental health and smoking cessation: a study of rural teens. Prevention Science : the Official Journal of the Society For Prevention Research. 5: 113-26. PMID 15134316 DOI: 10.1023/B:Prev.0000023081.55878.3A  0.188
2013 Nadkarni A, Kalsekar I, You M, Forbes R, Hebden T. Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy. Clinicoeconomics and Outcomes Research : Ceor. 5: 49-57. PMID 23378778 DOI: 10.2147/Ceor.S36526  0.187
2010 Marcum ZA, Maffeo CM, Kalsekar I. The impact of an immunization training certificate program on the perceived knowledge, skills and attitudes of pharmacy students toward pharmacy-based immunizations. Pharmacy Practice. 8: 103-8. PMID 25132877 DOI: 10.4321/S1886-36552010000200004  0.186
2011 Jing Y, Kalsekar I, Curkendall SM, Carls GS, Bagalman E, Forbes RA, Hebden T, Thase ME. Intent-to-treat analysis of health care expenditures of patients treated with atypical antipsychotics as adjunctive therapy in depression. Clinical Therapeutics. 33: 1246-57. PMID 21840058 DOI: 10.1016/j.clinthera.2011.07.015  0.182
2010 Kiel PJ, Rosenbeck LL, Kalsekar I, Baute J, Abdelqader S, Sullivan CK, Schwartz J, Srivastava S, Abonour R, Robertson MJ, Nelson RP, Fausel CA, Farag SS. Sirolimus Compared To Methotrexate Based Immunosuppression For Graft-versus-Host Disease (GvHD) Prophylaxis In Allogeneic Stem Cell Transplantation: A Single Institution Experience Biology of Blood and Marrow Transplantation. 16. DOI: 10.1016/J.Bbmt.2009.12.488  0.181
2014 Seabury SA, Goldman DP, Kalsekar I, Sheehan JJ, Laubmeier K, Lakdawalla DN. Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in Medicaid. The American Journal of Managed Care. 20: e52-60. PMID 24738555  0.18
2014 Farr AM, Sheehan JJ, Curkendall SM, Smith DM, Johnston SS, Kalsekar I. Retrospective analysis of long-term adherence to and persistence with DPP-4 inhibitors in US adults with type 2 diabetes mellitus. Advances in Therapy. 31: 1287-305. PMID 25504156 DOI: 10.1007/s12325-014-0171-3  0.176
2013 Halpern R, Nadkarni A, Kalsekar I, Nguyen H, Song R, Baker RA, Nelson JC. Medical costs and hospitalizations among patients with depression treated with adjunctive atypical antipsychotic therapy: an analysis of health insurance claims data. The Annals of Pharmacotherapy. 47: 933-45. PMID 23715066 DOI: 10.1345/Aph.1R622  0.175
2015 Johnston SS, Sheehan JJ, Shah M, Cappell K, Princic N, Kalsekar I, Smith D. Cardiovascular event costs in patients with Type 2 diabetes mellitus. Journal of Medical Economics. 1-31. PMID 26189723 DOI: 10.3111/13696998.2015.1074078  0.175
2014 Gersing KR, Sheehan JJ, Burchett B, Zhu L, Bates JA, Baker RA, Kalsekar ID. Use of augmentation agents for treating depression: analysis of a psychiatric electronic medical record data set. Psychiatric Services (Washington, D.C.). 65: 1062-5. PMID 24932958 DOI: 10.1176/appi.ps.201300288  0.174
2013 Citrome L, Guo Z, Kalsekar I, Forbes RA, Hebden T. Trends in combination antipsychotic use among persons with commercial insurance: a data snapshot. Innovations in Clinical Neuroscience. 9: 17-8. PMID 22567605  0.172
2013 Citrome L, Collins JM, Nordstrom BL, Rosen EJ, Baker R, Nadkarni A, Kalsekar I. Incidence of cardiovascular outcomes and diabetes mellitus among users of second-generation antipsychotics. The Journal of Clinical Psychiatry. 74: 1199-206. PMID 24434088 DOI: 10.4088/Jcp.13M08642  0.164
2015 Brett Hauber A, Nguyen H, Posner J, Kalsekar I, Ruggles J. A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetes. Current Medical Research and Opinion. 1-32. PMID 26549576 DOI: 10.1185/03007995.2015.1117433  0.162
2012 Sclar DA, Robison LM, Cohen LJ, Laubmeier KK, Kalsekar ID, Forbes RA. Use of a second generation antipsychotic among patients diagnosed with major depressive disorder in the United States: Prescribing pattern and influence of physician specialty Pharmaceutical Medicine. 26: 235-241. DOI: 10.2165/11635360  0.161
2014 Chang TE, Jing Y, Yeung AS, Brenneman SK, Kalsekar ID, Hebden T, McQuade RD, Baer L, Kurlander JL, Watkins AK, Siebenaler JA, Fava M. Depression monitoring and patient behavior in the Clinical Outcomes in MEasurement-Based Treatment (COMET) trial. Psychiatric Services (Washington, D.C.). 65: 1058-61. PMID 25082605 DOI: 10.1176/appi.ps.201300326  0.156
2016 Fu AZ, Johnston SS, Ghannam A, Tsai K, Cappell K, Fowler R, Riehle E, Cole AL, Kalsekar I, Sheehan J. Association Between Hospitalization for Heart Failure and Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes: An Observational Study. Diabetes Care. PMID 26740636 DOI: 10.2337/dc15-0764  0.144
2017 MacEwan JP, Sheehan JJ, Yin W, Vanderpuye-Orgle J, Sullivan J, Peneva D, Kalsekar I, Peters AL. The relationship between adherence and total spending among Medicare beneficiaries with type 2 diabetes. The American Journal of Managed Care. 23: 248-252. PMID 28554205  0.143
2016 Farr AM, Sheehan JJ, Brouillette M, Smith DM, Johnston SS, Kalsekar I. Healthcare Costs Among Adults with Type 2 Diabetes Initiating DPP-4 Inhibitors. Advances in Therapy. PMID 26724938 DOI: 10.1007/s12325-015-0277-2  0.143
2016 Wu B, Bell K, Stanford A, Kern DM, Tunceli O, Vupputuri S, Kalsekar I, Willey V. Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns-NHANES 2007-2012. Bmj Open Diabetes Research & Care. 4: e000154. PMID 27110365 DOI: 10.1136/bmjdrc-2015-000154  0.14
2023 Janssen EM, Smith IP, Liu X, Pierce A, Huang Q, Kalsekar I, Vachani A, Mansfield C. Patient Preferences for Lung Cancer Interception Therapy. Jama Network Open. 6: e2342681. PMID 37948077 DOI: 10.1001/jamanetworkopen.2023.42681  0.127
2013 Jing Y, Guo Z, Kalsekar I, Forbes RA, Hebden T, Thase ME. Dosing patterns of aripiprazole and quetiapine for adjunctive treatment of major depressive disorder (2006-2010). International Clinical Psychopharmacology. 28: 87-90. PMID 23262644 DOI: 10.1097/YIC.0b013e32835ce232  0.125
2003 Kalsekar ID, Makela EH, Moeller KE. Analysis of West Virginia medicaid claims data for the prevalence of medical conditions and use of drugs likely to cause QT prolongation in patients with schizophrenia. Current Therapeutic Research, Clinical and Experimental. 64: 538-50. PMID 24944403 DOI: 10.1016/j.curtheres.2003.08.007  0.124
2004 Kalsekar ID, Miller LA. Comment: Pharmacist intervention enhances adherence to orlistat therapy. The Annals of Pharmacotherapy. 38: 512. PMID 14999818 DOI: 10.1345/aph.1D183a  0.119
2019 Bhora F, Ghosh SK, Kassis E, Yoo A, Ramisetti S, Johnston SS, Rehmani S, Kalsekar I. Association of tumor location with economic outcomes and air leak complications in thoracic lobectomies: results from a national hospital billing dataset. Clinicoeconomics and Outcomes Research : Ceor. 11: 373-383. PMID 31239734 DOI: 10.2147/CEOR.S190644  0.117
2003 Massey CJ, Dino GA, Horn KA, Lacey-McCracken A, Goldcamp J, Kalsekar I. Recruitment barriers and successes of the American Lung Association's Not-On-Tobacco Program. The Journal of School Health. 73: 58-63. PMID 12643020  0.115
2014 Citrome L, Kalsekar I, Baker RA, Hebden T. A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults. Current Medical Research and Opinion. 30: 1629-41. PMID 24666104 DOI: 10.1185/03007995.2014.908280  0.112
2017 Roy S, Yoo A, Yadalam S, Fegelman EJ, Kalsekar I, Johnston SS. Comparison of economic and clinical outcomes between patients undergoing laparoscopic bariatric surgery with powered versus manual endoscopic surgical staplers. Journal of Medical Economics. 1-11. PMID 28270023 DOI: 10.1080/13696998.2017.1296453  0.11
2017 Kalsekar I, Hsiao CW, Cheng H, Yadalam S, Chen BP, Goldstein L, Yoo A. Economic burden of cancer among patients with surgical resections of the lung, rectum, liver and uterus: results from a US hospital database claims analysis. Health Economics Review. 7: 22. PMID 28577182 DOI: 10.1186/s13561-017-0160-8  0.109
2023 Laeseke P, Ng C, Ferko N, Naghi A, Wright GWJ, Zhang Y, Laidlaw A, Kalsekar I, Laxmanan B, Ghosh SK, Zhou M, Szapary P, Pritchett M. Stereotactic body radiation therapy and thermal ablation for treatment of NSCLC: A systematic literature review and meta-analysis. Lung Cancer (Amsterdam, Netherlands). 182: 107259. PMID 37321074 DOI: 10.1016/j.lungcan.2023.107259  0.108
2017 Yoo A, Ghosh SK, Danker W, Kassis E, Kalsekar I. Burden of air leak complications in thoracic surgery estimated using a national hospital billing database. Clinicoeconomics and Outcomes Research : Ceor. 9: 373-383. PMID 28721079 DOI: 10.2147/CEOR.S133830  0.107
2002 Amonkar MM, Kalsekar ID, Boyer JG, Monsanto HA, Mallet L. The economic burden of Barrett's esophagus in a Medicaid population Annals of Pharmacotherapy. 36: 605-611. PMID 11918506 DOI: 10.1345/Aph.1A309  0.102
2020 Fortin SP, Kalsekar I, Johnston S, Akincigil A. Comparison of safety and utilization outcomes in inpatient versus outpatient laparoscopic sleeve gastrectomy: a retrospective, cohort study. Surgery For Obesity and Related Diseases : Official Journal of the American Society For Bariatric Surgery. PMID 32811709 DOI: 10.1016/J.Soard.2020.07.012  0.1
2019 Johnston SS, Morton JM, Kalsekar I, Ammann EM, Hsiao CW, Reps J. Using Machine Learning Applied to Real-World Healthcare Data for Predictive Analytics: An Applied Example in Bariatric Surgery. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 22: 580-586. PMID 31104738 DOI: 10.1016/j.jval.2019.01.011  0.097
2017 Etter K, Davis B, Roy S, Kalsekar I, Yoo A. Economic Impact of Laparoscopic Conversion to Open in Left Colon Resections. Jsls : Journal of the Society of Laparoendoscopic Surgeons. 21. PMID 28890650 DOI: 10.4293/JSLS.2017.00036  0.092
2015 Vaidya V, Adhikari K, Sheehan J, Kalsekar I. Comparison of charges and resource use associated with saxagliptin and sitagliptin. Health Economics Review. 6: 26. PMID 27388897 DOI: 10.1186/s13561-016-0104-8  0.088
2013 Citrome L, Kalsekar I, Guo Z, Laubmeier K, Hebden T. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis. Clinical Therapeutics. 35: 1867-75. PMID 24119767 DOI: 10.1016/j.clinthera.2013.09.006  0.088
2019 Ammann EM, Kalsekar I, Yoo A, Scamuffa R, Hsiao CW, Stokes AC, Morton JM, Johnston SS. Assessment of obesity prevalence and validity of obesity diagnoses coded in claims data for selected surgical populations: A retrospective, observational study. Medicine. 98: e16438. PMID 31335698 DOI: 10.1097/MD.0000000000016438  0.084
2022 Vachani A, Zhou M, Ghosh S, Zhang S, Szapary P, Gaurav D, Kalsekar I. Complications After Transthoracic Needle Biopsy of Pulmonary Nodules: A Population-Level Retrospective Cohort Analysis. Journal of the American College of Radiology : Jacr. PMID 35738412 DOI: 10.1016/j.jacr.2022.04.010  0.08
2023 Rajaram R, Huang Q, Li RZ, Chandran U, Zhang Y, Amos TB, Wright GW, Ferko NC, Kalsekar I. Recurrence-free survival (RFS) in Surgically-Resected Non-Small Cell Lung Cancer (NSCLC) Patients - A Systematic Literature Review and Meta-analysis. Chest. PMID 38065405 DOI: 10.1016/j.chest.2023.11.042  0.079
2023 Vachani A, Zhou M, Ghosh S, Zhang S, Szapary P, Gaurav D, Kalsekar I. Complications Following Transthoracic Needle Biopsy of Pulmonary Nodules: A Population-level Retrospective Cohort Analysis: Authors' Response. Journal of the American College of Radiology : Jacr. PMID 37302682 DOI: 10.1016/j.jacr.2023.04.009  0.074
2023 Khan F, Seaman J, Hunter TD, Ribeiro D, Laxmanan B, Kalsekar I, Cumbo-Nacheli G. Diagnostic outcomes of robotic-assisted bronchoscopy for pulmonary lesions in a real-world multicenter community setting. Bmc Pulmonary Medicine. 23: 161. PMID 37161376 DOI: 10.1186/s12890-023-02465-w  0.063
2023 Vachani A, Maldonado F, Laxmanan B, Zhou M, Kalsekar I, Szapary P, Dooley L, Murgu S. The Effect of Definitions and Cancer Prevalence on Diagnostic Yield Estimates of Bronchoscopy: A Simulation-Based Analysis. Annals of the American Thoracic Society. PMID 37311211 DOI: 10.1513/AnnalsATS.202302-182OC  0.055
2024 Laeseke P, Ng C, Naghi A, Wright GWJ, Laxmanan B, Ghosh SK, Amos TB, Kalsekar I, Pritchett M. Response to letter: Microwave ablation for Early-Stage Non-Small cell Lung Cancer: Don't Put the Cart before the stereotactic Horse. Lung Cancer (Amsterdam, Netherlands). 189: 107504. PMID 38368724 DOI: 10.1016/j.lungcan.2024.107504  0.051
2017 Etter K, Lerner J, Kalsekar I, de Moor C, Yoo A, Swank M. Comparative Analysis of Hospital Length of Stay and Discharge Status of Two Contemporary Primary Total Knee Systems. The Journal of Knee Surgery. PMID 28841727 DOI: 10.1055/s-0037-1604442  0.046
2023 McClure T, Lansing A, Ferko N, Wright G, Ghosh SK, Raza S, Kalsekar I, Clarke K, Talenfeld A. A Comparison of Microwave Ablation and Cryoablation for the Treatment of Renal Cell Carcinoma: A Systematic Literature Review and Meta-Analysis. Urology. PMID 37331485 DOI: 10.1016/j.urology.2023.06.001  0.046
2018 Ammann EM, Kalsekar I, Yoo A, Johnston SS. Validation of body mass index (BMI)-related ICD-9-CM and ICD-10-CM administrative diagnosis codes recorded in US claims data. Pharmacoepidemiology and Drug Safety. PMID 30003617 DOI: 10.1002/pds.4617  0.043
2022 Chandran U, Reps J, Yang R, Vachani A, Maldonado F, Kalsekar I. Machine Learning and Real-World Data to Predict Lung Cancer Risk in Routine Care. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 36576991 DOI: 10.1158/1055-9965.EPI-22-0873  0.042
2024 Shafrin J, Kim J, Marin M, Ramsagar S, Davies ML, Stewart K, Kalsekar I, Vachani A. Quantifying The Value of Reduced Health Disparities: Low-Dose CT Lung Cancer Screening of High-Risk Individuals within the US. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. PMID 38191024 DOI: 10.1016/j.jval.2023.12.014  0.042
2021 Vachani A, Maldonado F, Laxmanan B, Kalsekar I, Murgu S. The Impact of Alternative Approaches to Diagnostic Yield Calculation in Studies of Bronchoscopy. Chest. PMID 34506792 DOI: 10.1016/j.chest.2021.08.074  0.038
2021 Johnston SS, Fortin S, Kalsekar I, Reps J, Coplan P. Improving visual communication of discriminative accuracy for predictive models: the probability threshold plot. Jamia Open. 4: ooab017. PMID 33733059 DOI: 10.1093/jamiaopen/ooab017  0.01
Hide low-probability matches.